Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections

Journal of Human Virology

Volumn 2, Issue 1, 1999, Pages 45-51

  Sarr, Abdoulaye Dieng ^a   Popper, Stephen ^a   Thior, Ibou ^a   Hamel, Donald J ^a   Sankalé, Jean Louis ^a   Siby, Tidiane ^b   Marlink, Richard ^a   Essex, Max ^a   Mboup, Souleymane ^b   Kanki, Phyllis ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

CD4+ lymphocyte counts; Dual infection; HIV 1; HIV 2; Proviral load

Indexed keywords

ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROSTITUTION; SENEGAL; STATISTICAL ANALYSIS; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-2; HUMANS; PROVIRUSES; VIRAL LOAD;

EID: 0033508950     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Peeters M, Gershy-Damet GM, Fransen K, et al. Virological and polymerase chain reaction studies of HIV-1/ HIV-2 dual infection in Cote d'Ivoire. Lancet 1992;340: 339-340.
2. Rayfield M, De Cock K, Heyward W, et al. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis 1988;158:1170-1176.
3. Leonard G, Chaput A, Courgnaud V, Sangare A, Denis F, Brechot C. Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993;7:1185-1189.
4. George JR, Ou CY, Parekh B, et al. Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 1992; 340:337-339.
5. Evans LA, Moreau J, Odehouri K, et al. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 1988;2:1389-1391.
6. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Dual seroreactivity to HIV-1 and HIV-2 in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1995;9:955-958.
7. Gnann JW Jr, McCormick JB, Mitchell S, Nelson JA, Oldstone MB. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 1987;237: 1346-1349.
8. Kanki PJ, Peeters M, Gueye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa. AIDS 1997;11:S33-42.
9. Sarr AD, Popper S, Thior I, et al. Quantitative competitive PCR for assessment of proviral load in HIV-2 infected individual in Senegal. X International Conference on AIDS and STDs in Africa, Abidjan, Cote d'Ivoire, 1997:A.071.
10. Ariyoshi K, Cham F, Berry N, et al. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 1995;9:555-559.
11. + lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994;10:1031-1037.
12. Ariyoshi K, Berry N, Wilkins A, et al. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis 1996;173: 245-248.
13. Clarke JR, Gates AJ, Coker RJ, Douglass JA, Williamson JD, Mitchell DM. HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients. Clin Exp Immunol 1994;96:182-186.
14. Lefrere JJ, Mariotti M, Wattel E, et al. Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individuals. Br J Haematol 1992;82:467-471.
15. Michael NL, Vahey M, Burke DS, Redfield RR. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992;66:310-316.
16. Norrgren H, Marquina S, Leitner T, et al. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:31-38.
17. Schmid P, Conrad A, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:777-788.
18. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJ. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990;64:864-872.
19. Dickover RE, Donovan RM, Goldstein E, Dandekar S, Bush CE, Carlson JR. Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction. J Clin Microbiol 1990;28:2130-2133.
20. Jurriaans S, Dekker JT, de Ronde A. HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS 1992;6:635-641.
21. Kanki P, Mboup S, Marlink R, et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in West African female prostitutes. Am J Epidemiol 1992;136:895-907.
22. Kanki PJ, Travers KU, Mboup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-946.
23. Gueye-Ndiaye A, Clark RJ, Samuel KP, et al. Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/996) dot-blot analysis. AIDS 1993;7:475-481.
24. + lymphocyte counts. AIDS 1998;12:131-137.
25. Grankvist O, Bredberg-Raden U, Gustafsson A, et al. Improved detection of HIV-2 DNA in clinical samples using a nested primer-based polymerase chain reaction. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:286-293.
26. Diviacco S, Norio P, Zentilin L, et al. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 1992;122:313-320.
27. Shibata R, Miura T, Hayami M, et al. Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J Virol 1990;64:742-747.
28. Aaby P, Ariyoshi K, Buckner M, et al. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. AIDS 1996;10:1585-1590.
29. Peeters M, Fransen K, Gershy-Damet GM, et al. Effect of methodology on detection of HIV-1/HIV-2 dual infections in Cote d'Ivoire. J Virol Methods 1994;48:23-30.
30. N'Gbichi JM, De Cock KM, Batter V, et al. HIV status of female sex partners of men reactive to HIV-1, HIV-2 or both viruses in Abidjan, Cote d'Ivoire. AIDS 1995;9:951-954.
31. Sankalé J-L, Mboup S, Essex M, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1 and HIV-2 infected women. AIDS Res Hum Retroviruses 1998;14:1473-1481.
32. Sankalé J-L, de la Tour RS, Renjifo B, et al. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses 1995;11: 617-623.
33. + T cells are an important site of HIV replication in vivo. AIDS 1997;11:849-857.
34. Saksela K, Muchmore E, Girard M, Fultz P, Baltimore D. High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol 1993;67:7423-7427.